Lisdexamfetamine Dimesylate Capsule
Apotex Corp. · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 11/01/2023
- Package NDC
- 60505-4743-1
- Generic name
- Lisdexamfetamine Dimesylate Capsule
- Contact info
- 800-706-5575
- Availability
- Available
- Update date
- 11/17/2026
- Dosage form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1)
- Company name
- Apotex Corp.
- Status
- Current
- Therapeutic category
- Psychiatry
- Harmonized identifiers (openFDA)
- Application number
- ANDA216944
- Brand name
- LISDEXAMFETAMINE DIMESYLATE
- Generic name
- LISDEXAMFETAMINE DIMESYLATE
- Manufacturer name
- Apotex Corp.
- Product NDC
- 60505-4743, 60505-4739, 60505-4740, 60505-4741, 60505-4742, 60505-4744, 60505-4745
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- LISDEXAMFETAMINE DIMESYLATE
- RxCUI
- 854830, 854834, 854838, 854842, 854846, 854850, 1593856
- SPL ID
- 0190bec9-05e4-0977-9548-2cc150b53e74
- SPL set ID
- ecad4442-a644-18e3-6ff2-fdbac45eec47
- Package NDC
- 60505-4739-1, 60505-4740-1, 60505-4741-1, 60505-4742-1, 60505-4743-1, 60505-4744-1, 60505-4745-1
- UNII
- SJT761GEGS
